IL18BP and colitis: In 2015, the groups of Flavell and Elinav showed that deletion of the IL-18 gene or its receptor (Il18r1) in mouse intestinal epithelial cells conferred protection from colitis and mucosal damage, while the deletion of the IL-18BP gene resulted in severe colitis associated with the loss of mature goblet cells and lethality.